Relative contribution of VKORC1, CYP2C9, and INR response to warfarin stable dose

被引：15
作者：
Suarez-Kurtz, Guilherme [1 ]
Perini, Jamila A. [1 ]
Silva-Assuncao, Edimilson [1 ]
Struchiner, Claudio J. [1 ]
机构：
[1] Inst Nacl Canc, Div Farmacol, BR-21230050 Rio De Janeiro, Brazil
来源：
BLOOD | 2009年 / 113卷 / 17期
关键词：
POLYMORPHISMS; REQUIREMENTS;
D O I：
10.1182/blood-2009-01-200600
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4125 / 4126
页数：2
相关论文
共 50 条
  • [41] ARMS test for diagnosis of CYP2C9 and VKORC1 mutation in patients with pulmonary embolism in Han Chinese
    Zhu, Jin
    Zhang, Weijuan
    Li, Yanyan
    Zhang, Wei
    Wang, Heyao
    Zheng, Wenjie
    Wang, Chen
    PHARMACOGENOMICS, 2010, 11 (01) : 113 - 119
  • [42] Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population
    Mahvash Farajzadeh-Dehkordi
    Fatemeh Samiee-Rad
    Seyed Saeed Farzam
    Amir Javadi
    Sara Cheraghi
    Dariush Hamedi-Asl
    Babak Rahmani
    Pharmacological Reports, 2023, 75 : 695 - 704
  • [43] Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX
    Fohner, Alison E.
    Robinson, Renee
    Yracheta, Joseph
    Dillard, Denise A.
    Schilling, Brian
    Khan, Burhan
    Hopkins, Scarlett
    Boyer, Bert B.
    Black, Jynene
    Wiener, Howard
    Tiwari, Hemant K.
    Gordon, Adam
    Nickerson, Deborah
    Tsai, Jesse M.
    Farin, Federico M.
    Thornton, Timothy A.
    Rettie, Allan E.
    Thummel, Kenneth E.
    PHARMACOGENETICS AND GENOMICS, 2015, 25 (07) : 343 - 353
  • [44] CYP2C9 and VKORC1 in therapeutic dosing and safety of acenocoumarol treatment: implication for clinical practice in Hungary
    Varnai, Reka
    Sipeky, Csilla
    Nagy, Lajos
    Balogh, Sandor
    Melegh, Bela
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2017, 56 : 282 - 289
  • [45] A new algorithm to predict warfarin dose from polymorphisms of CYP4F2, CYP2C9 and VKORC1 and clinical variables: Derivation in Han Chinese patients with non valvular atrial fibrillation
    Wei, Meng
    Ye, Fei
    Xie, Dujiang
    Zhu, Yubing
    Zhu, Junrong
    Tao, Yifu
    Yu, Feng
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (06) : 1083 - 1091
  • [46] Warfarin maintenance dose associated with genetic polymorphisms of CYP2C9
    Khaleqsefat, E.
    Khalaj-Kondori, M.
    Bonyadi, Jabbarpour M.
    Battaloglu, E.
    HIPPOKRATIA, 2017, 21 (02) : 93 - 96
  • [47] CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies
    Villagra, David
    Duconge, Jorge
    Windemuth, Andreas
    Cadilla, Carmen L.
    Kocherla, Mohan
    Gorowski, Krystyna
    Bogaard, Kali
    Renta, Jessica Y.
    Cruz, Irelys A.
    Mirabal, Sara
    Seip, Richard L.
    Ruano, Gualberto
    CLINICA CHIMICA ACTA, 2010, 411 (17-18) : 1306 - 1311
  • [48] Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment
    Jose Cerezo-Manchado, Juan
    Roldan, Vanessa
    Rosafalco, Mario
    Isabel Anton, Ana
    Belen Arroyo, Ana
    Garcia-Barbera, Nuria
    Belen Martinez, Ana
    Padilla, Jose
    Corral, Javier
    Vicente, Vicente
    Gonzalez-Conejero, Rocio
    PHARMACOGENOMICS, 2014, 15 (07) : 987 - 996
  • [49] Impact of VKORC1, CYP2C9, CYP1A2, UGT1A1, and GGCX polymorphisms on warfarin maintenance dose: Exploring a new algorithm in South Chinese patients accept mechanical heart valve replacement
    Li, Jin
    Chen, Tao
    Jie, Fangfang
    Xiang, Haiyan
    Huang, Li
    Jiang, Hongfa
    Lu, Fei
    Zhu, Shuqiang
    Wu, Lidong
    Tang, Yanhua
    MEDICINE, 2022, 101 (29) : E29626
  • [50] A New Algorithm for Weekly Phenprocoumon Dose Variation in a Southern Brazilian Population: Role for CYP2C9, CYP3A4/5 and VKORC1 Genes Polymorphisms
    Botton, Mariana R.
    Viola, Patricia P.
    Bandinelli, Eliane
    Leiria, Tiago L. L.
    Rohde, Luis E. P.
    Hutz, Mara H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 114 (04) : 323 - 329
12345